Senna

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Senna
Generic name: SENNOSIDES 8.6 MG TABLETS
Manufacturer: Aarkish Pharmaceuticals NJ Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 564bc9a5-13b5-4cce-a349-6b2e122683ed
SPL ID: 56d3eab0-0040-da54-e063-6294a90a09e2
Version: 1
Effective date: 2026-07-01
Source export date: 2026-11-06
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/97001096994db9ca8cee114e6c3bb5298d3c573158ffc1ab8692d82e76a3eb40/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 06:56:07

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M007	openfda.application_number
brand name		Senna	openfda.brand_name
generic name		SENNOSIDES 8.6 MG TABLETS	openfda.generic_name
manufacturer name		Aarkish Pharmaceuticals NJ Inc.	openfda.manufacturer_name
ndc	package	81005-101-10	openfda.package_ndc
ndc	package	81005-101-30	openfda.package_ndc
ndc	product	81005-101	openfda.product_ndc
ndc11	package	81005010110	derived:openfda.package_ndc
ndc11	package	81005010130	derived:openfda.package_ndc
rxcui		312935	openfda.rxcui
spl id		56d3eab0-0040-da54-e063-6294a90a09e2	id
spl set id		564bc9a5-13b5-4cce-a349-6b2e122683ed	set_id
unii		3FYP5M0IJX	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS ASK A DOCTOR BEFORE USE IF stomach pain nausea vomiting noticed a sudden change in bowel habits that continues over a period of 2 weeks STOP USE AND ASK DOCTOR IF you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition. PREGNANCY/BREASTFEEDING ask a health professional before use. KEEP OUT OF REACH OF CHILDREN In case of overdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.